The roles of a process development group in biopharmaceutical process startup

Area of Science:

• Biopharmaceutical Manufacturing
• Process Development
• Technology Transfer

Background:

• Historically, the transfer of biotherapeutic manufacturing processes into facilities faced significant challenges in the 1980s and early 1990s.
• These challenges often led to costly delays in product licensure and market entry.
• Process startup issues were common but not inherent to biopharmaceutical manufacturing.

Purpose of the Study:

• To identify major classes of process startup problems in biopharmaceutical manufacturing.
• To present mechanisms developed to mitigate the occurrence of these startup problems.
• To emphasize the critical role of the Process Development Group in successful technology transfer and facility startup.

Main Methods:

• Analysis of historical process startup challenges in biopharmaceutical manufacturing.
• Identification and categorization of common process startup problems.
• Review of established mechanisms and strategies for problem resolution.

Main Results:

• Major classes of process startup problems have been identified.
• Effective mechanisms for reducing the likelihood of these problems have been developed.
• High probability of smooth process startup, with successful performance often achieved within the first two full-scale process lots, is attainable.

Conclusions:

• Process startup issues in biopharmaceutical manufacturing are manageable with proper planning and adequate staffing.
• The Process Development Group is instrumental in ensuring a high probability of success for biopharmaceutical product manufacturing.
• Implementing identified resolution mechanisms can lead to efficient and timely facility startups and licensure.